Document Detail


15-hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor gamma-dependent pathway.
MedLine Citation:
PMID:  14566836     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Peroxisome proliferator-activated receptor gamma (PPARgamma) inhibits cell growth via promoting apoptosis. Human colorectal cancer tissues had abundant PPARgamma but the incidence of apoptosis was very low, suggesting a defect in the PPARgamma pathway. Here, we found that 15-hydroxy-eicosatetraenoic acid (15S-HETE), an endogenous ligand for PPARgamma, was significantly decreased in the serum of patients with colorectal cancer. Treatment of colon cancer cells with 15S-HETE inhibited cell proliferation and induced apoptosis, which was preceded by an increase in TGF-beta-inducible early gene (TIEG) and a decrease in Bcl-2. The action of 15S-HETE could be blocked when PPARgamma was suppressed. Overexpression of Bcl-2 prevented the apoptosis. The levels of TIEG and 15-lipoxygenase (15-LOX), the enzyme responsible for 15S-HETE production, was decreased in colorectal cancer. Therefore, colorectal cancer is associated with decreased 15S-HETE. Treatment of colon cancer cells with 15S-HETE inhibits cell proliferation and induces apoptosis in a PPARgamma-dependent pathway involving augmentation of TIEG and reduction of Bcl-2 expression.
Authors:
George G Chen; Hu Xu; Janet F Y Lee; Malayannan Subramaniam; Ka L Leung; Su H Wang; Ursula P F Chan; Thomas C Spelsberg
Related Documents :
25026246 - A novel oleanolic acid-loaded plga-tpgs nanoparticle for liver cancer treatment.
23066176 - Development of sirna lipoplexes for intracellular delivery in lung cancer cells.
23775566 - The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates t...
16816356 - Role of the survivin gene in pathophysiology.
15916506 - Setting educational priorities for women's preventive health: measuring beliefs about s...
1325576 - Investigation of colon cancers for human papillomavirus genomic sequences by polymerase...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  107     ISSN:  0020-7136     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2003-10-20     Completed Date:  2004-02-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  837-43     Citation Subset:  IM    
Copyright Information:
Copyright 2003 Wiley-Liss, Inc.
Affiliation:
Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong Kong. gchen@cuhk.edu.hk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis / drug effects
Cell Division / drug effects*
Cell Survival / drug effects
Colonic Neoplasms / pathology
DNA-Binding Proteins / metabolism
Early Growth Response Transcription Factors
Humans
Hydroxyeicosatetraenoic Acids / pharmacology*
Immunohistochemistry
Kruppel-Like Transcription Factors
Lipoxygenase / metabolism
Receptors, Cytoplasmic and Nuclear / drug effects,  genetics,  physiology*
Recombinant Proteins / drug effects
Rectal Neoplasms / pathology
Transcription Factors / drug effects,  genetics,  metabolism,  physiology*
Transfection
Tumor Cells, Cultured
Grant Support
ID/Acronym/Agency:
DE14036/DE/NIDCR NIH HHS
Chemical
Reg. No./Substance:
0/DNA-Binding Proteins; 0/Early Growth Response Transcription Factors; 0/Hydroxyeicosatetraenoic Acids; 0/KLF10 protein, human; 0/Kruppel-Like Transcription Factors; 0/Receptors, Cytoplasmic and Nuclear; 0/Recombinant Proteins; 0/Transcription Factors; 73945-47-8/15-hydroxy-5,8,11,13-eicosatetraenoic acid; EC 1.13.11.12/Lipoxygenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by lim...
Next Document:  Nonsteroidal anti-inflammatory drugs inhibit growth of human neuroendocrine tumor cells via G1 cell-...